Leadership

Companies
- GI Dynamics
- Systagenix
- CentriMed / GHX
- IST
Experience
- Multiple clinical trials / regulatory approvals
- Multiple exits
- >$150m raised: public / private
- Patents: 25 issued/pending
Education:
- A.B: Dartmouth College
- B.E.: Thayer School of Engineering, Dartmouth College
- US Army Airborne Ranger

Companies
- Medtronic
- Millennium
- Corning
- Lynx / Solexa
- Roche
Experience
- Multiple clinical trials
- Patents: 10 issued/pending
- Publications: 26+
Education:
- B.S. Chemistry: MIT
- PhD Genetics: Harvard University
- Postdoc, Developmental Biology: Princeton University

Companies
• Janssen
• Ethicon
• Covidean
• Fractyl
• GI Dynamics
Experience
20+ clinical practice
• Multiple clinical trials funded by NIDDK, ADA and industry
• Publications: 120+
Education
• B.S. Biological Science, UC Irvine
• MD UC Irvine College of Medicine
• Postdoc, T32 and NRSA-NIDDK

Mr. Freeman has 25 years of finance, operations and management experience across a variety of industries including medical device, technology, industrial manufacturing, and professional services. He has worked in a wide range of environments, ranging from large public multi-national corporations down to small emerging private companies. Jon has helped lead several companies that have realized substantial shareholder value. Mr. Freeman holds a BA in Economics from St. Olaf College and an MBA from the University of Texas at Austin.
Scientific Advisors | Endocrinology

- 30+ yrs continuous NIH-funded research
- Founding Director, Weight Management Clinic and Program at the Seattle/Tacoma VA Hospital network
- >170 publications plus many book chapters
- 30+ years treating patients with obesity
- Advisor: Gila Therapeutics, GI Dynamics, Metavention, DyaMx

- 20+ yrs treating patients with obesity
- Founder and Director, Metabolic and Weight Control Center at Columbia
- Chair and Diplomate of the American Board of Obesity Medicine
- 20+ yrs NIH-funded research
- Advisor: Gila Therapeutics, GI Dynamics, Digma Medical, Found Health

- 25+ yrs treating patients with obesity
- Head, Metabolic Medicine & Obesity Complications Clinic
- >340 publications cited >15,000 times
- Advisor: Gila Therapeutics, Novo Nordisk, Johnson&Johnson, Herbalife, Boehringer Ingelheim

Experience
- 30+ yrs treating patients with obesity
- >200 publication & 45 book chapter and reviews
- President of World Obesity Federation
- Former President of The Obesity Society
- Advisor: Gila Therapeutics, Novo Nordisk, Takeda, Vivus, Eisai, Calibrate
Scientific Advisors | Nephrology

- Global leader, movement to improve management of obesity in chronic kidney disease
- Board certified in internal medicine, nephrology, and nutrition
- 25+ years treating patients throughout the range of kidney disease
- Adviser: Gila Therapeutics, GI Dynamics, Goldfinch Bio, Astra Zeneca
Scientific Advisors | Neuroscience

- 23 years working in drug development
- Founder Orexigen Therapeutics, Monash Obesity & Diabetes Institute
- Authored over 130 papers and chapters.
- Inventor of 180 patent or patent applications (including PCT’s)
- Advisor Gila Therapeutics, Novo Nordisk, iNova, Acino, Curris.

- 40+ years of NIH funding
- 200 published papers and reviews
- Former President of The Obesity Society and Society for the Study of Ingestive Behavior
- Advisor: Gila Therapeutics, Pfizer, Novo Nordisk, Janssen

- +40 years conducting research on gustation and ingestive behavior in preclinical models
- Former President of the Society for the Study of Ingestive Behavior and the Association of Chemoreception Science
- Fellow of the: American Psychological Association, Association for Psychological Science, and the American Association for the Advancement of Science
- Continuously funded from the NIH for 35 years
- >165 publications
- Advisor: Gila Therapeutics
Board of Directors

Companies
- GI Dynamics
- Systagenix
- CentriMed / GHX
- IST
Experience
- Multiple clinical trials / regulatory approvals
- Multiple exits
- >$150m raised: public / private
- Patents: 25 issued/pending
Education:
- A.B: Dartmouth College
- B.E.: Thayer School of Engineering, Dartmouth College
- US Army Airborne Ranger

Biograph Venture
Biograph is an independent venture development firm established in 2018, focused in life sciences and healthcare
Previous positions:
- Slater Technology Fund, Providence, RI
- Sachem Ventures, Princeton, NJ
- Johnston Associates, Princeton, NJ
CEO Positions
- Medical Media Systems
- SEQ/Praelux
- Immunicon Corp
Education:
- A.B.: Dartmouth College
- MBA: Tuck School at Dartmouth

Broadview Ventures
Broadview is a philanthropic, for-profit venture fund supported by the Leducq Family Trust with a mission to accelerate the development of promising technology in cardiovascular and neurovascular disease through targeted investments in and support of early-stage ventures
Current Director positions:
- MassBio
- Acesion, Mellitus, Giner Life Science
Education:
- B.S., M.S.: University Mumbai
- M.S., PhD: LSU
- MBA: Rutgers University

Experience
40+ years in medical device and pharmaceutical companies
Companies
- Sepracor
- Verastem (NASDAQ: VSTM)
- Frequency Therapeutics (NASDAQ: FREQ)
- TScan Therapeutics (NASDAQ: TCRX)
Founder and CEO
- Sepracor: Founder & CEO (NASDAQ: SEPR) Sold to Dainippon for $2.6Bn
Education:
- B.S. in Chemistry from Kings College